Early Identification and Management of Patients with Severe Sepsis and Septic Shock in the Emergency Department

Emergency Medicine Clinics of North America

Volumn 32, Issue 4, 2014, Pages 759-776

  Keegan, Joshua ^a   Wira, Charles R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Early goal directed therapy; Organ dysfunction; Sepsis; Sepsis bundles; Shock

Indexed keywords

ANTIBIOTIC AGENT; DOBUTAMINE; GLUCOSE; HYDROCORTISONE; HYPERTENSIVE AGENT; INOTROPIC AGENT; LACTIC ACID; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN; VASOCONSTRICTOR AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; BLOOD TRANSFUSION; CENTRAL VENOUS PRESSURE; DISEASE SEVERITY; ECHOGRAPHY; EMERGENCY CARE; FLUID RESUSCITATION; GLYCEMIC CONTROL; HEART AFTERLOAD; HEART PRELOAD; HIGH RISK PATIENT; HUMAN; HYPOTENSION; HYPOVOLEMIA; HYPOXEMIA; INSULIN TREATMENT; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MORTALITY; NEAR INFRARED SPECTROSCOPY; OXYGEN SATURATION; PATHOPHYSIOLOGY; PROGNOSIS; PROTOCOL COMPLIANCE; REVIEW; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; ALGORITHM; EMERGENCY HEALTH SERVICE; RISK ASSESSMENT; SHOCK, SEPTIC;

ALGORITHMS; EMERGENCY SERVICE, HOSPITAL; HUMANS; RISK ASSESSMENT; SEPSIS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84913584066     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.emc.2014.07.002     Document Type: Review

References (146)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Gaieski D.F., Edwards J.M., Kallan M.J., et al. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 2013, 41:1167-1174.
3. Vincent J.L., Sakr Y., Sprung C.L., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353.
4. Annane D., Aegerter P., Jars-Guincestre M.C., et al. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 168:165-172.
5. Dombrovskiy V.Y., Martin A.A., Sunderram J., et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35:1244-1250.
6. Catenacci M.H., King K. Severe sepsis and septic shock: improving outcomes in the emergency department. Emerg Med Clin North Am 2008, 26:603-623. vii.
7. Degoricija V., Sharma M., Legac A., et al. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy. Croat Med J 2006, 47:385-397.
8. Kumar G., Kumar N., Taneja A., et al. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 2011, 140:1223-1231.
9. Schrier R.W., Wang W. Acute renal failure and sepsis. NEngl J Med 2004, 351:159-169.
10. Freitas F.G., Salomao R., Tereran N., et al. The impact of duration of organ dysfunction on the outcome of patients with severe sepsis and septic shock. Clinics (Sao Paulo) 2008, 63:483-488.
11. Farcy D.A. Critical care emergency medicine 2012, McGraw-Hill Medical, New York.
12. Wang H.E., Shapiro N.I., Angus D.C., et al. National estimates of severe sepsis in United States emergency departments. Crit Care Med 2007, 35:1928-1936.
13. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
14. Angus D.C., van der Poll T. Severe sepsis and septic shock. NEngl J Med 2013, 369:840-851.
15. Cerra F.B. The systemic septic response: multiple systems organ failure. Crit Care Clin 1985, 1:591-607.
16. van der Poll T., Opal S.M. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008, 8:32-43.
17. Hotchkiss R.S., Tinsley K.W., Swanson P.E., et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. JImmunol 2002, 168:2493-2500.
18. Inoue S., Suzuki-Utsunomiya K., Okada Y., et al. Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit Care Med 2013, 41:810-819.
19. Torgersen C., Moser P., Luckner G., et al. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg 2009, 108:1841-1847.
20. Limaye A.P., Kirby K.A., Rubenfeld G.D., et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008, 300:413-422.
21. Opal S.M. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol 2007, 297:365-377.
22. Morrison D.C., Bucklin S.E. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis. Scand J Infect Dis Suppl 1996, 101:3-8.
23. Russell J.A. Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care 2011, 15:226.
24. Sayk F., Vietheer A., Schaaf B., et al. Endotoxemia causes central downregulation of sympathetic vasomotor tone in healthy humans. Am J Physiol Regul Integr Comp Physiol 2008, 295:R891-R898.
25. Rudiger A., Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007, 35:1599-1608.
26. Bouhemad B., Nicolas-Robin A., Arbelot C., et al. Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med 2008, 36:766-774.
27. Goldenberg N.M., Steinberg B.E., Slutsky A.S., et al. Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med 2011, 3:88ps25.
28. Wo C.C., Shoemaker W.C., Appel P.L., et al. Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness. Crit Care Med 1993, 21:218-223.
29. Levy R.J., Deutschman C.S. Cytochrome c oxidase dysfunction in sepsis. Crit Care Med 2007, 35:S468-S475.
30. Galley H.F. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011, 107:57-64.
31. Zhang Q., Raoof M., Chen Y., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
32. Hotchkiss R.S., Tinsley K.W., Swanson P.E., et al. Endothelial cell apoptosis in sepsis. Crit Care Med 2002, 30:S225-S228.
33. Funk D., Sebat F., Kumar A. Asystems approach to the early recognition and rapid administration of best practice therapy in sepsis and septic shock. Curr Opin Crit Care 2009, 15:301-307.
34. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
35. Filbin M.R., Arias S.A., Camargo C.A., et al. Sepsis visits and antibiotic utilization in U.S. Emergency Departments. Crit Care Med 2014, 42:528-535.
36. Sebat F., Musthafa A.A., Johnson D., et al. Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years. Crit Care Med 2007, 35:2568-2575.
37. Marchick M.R., Kline J.A., Jones A.E. The significance of non-sustained hypotension in emergency department patients with sepsis. Intensive Care Med 2009, 35:1261-1264.
38. Berger T., Green J., Horeczko T., et al. Shock index and early recognition of sepsis in the emergency department: pilot study. West J Emerg Med 2013, 14:168-174.
39. Rady M.Y., Smithline H.A., Blake H., et al. Acomparison of the shock index and conventional vital signs to identify acute, critical illness in the emergency department. Ann Emerg Med 1994, 24:685-690.
40. Lee S.W., Hong Y.S., Park D.W., et al. Lactic acidosis not hyperlactatemia as a predictor of in hospital mortality in septic emergency patients. Emerg Med J 2008, 25:659-665.
41. Mikkelsen M.E., Miltiades A.N., Gaieski D.F., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009, 37:1670-1677.
42. Vitek V., Cowley R.A. Blood lactate in the prognosis of various forms of shock. Ann Surg 1971, 173:308-313.
43. Shapiro N.I., Howell M.D., Talmor D., et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 2005, 45:524-528.
44. Wacharasint P., Nakada T.A., Boyd J.H., et al. Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock 2012, 38:4-10.
45. Jiwaji Z., Brady S., McIntyre L.A., et al. Emergency department management of early sepsis: a national survey of emergency medicine and intensive care consultants. Emerg Med J 2013, [Epub ahead of print].
46. Arnold R.C., Shapiro N.I., Jones A.E., et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock 2009, 32:35-39.
47. Nguyen H.B., Rivers E.P., Knoblich B.P., et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004, 32:1637-1642.
48. Berkman M., Ufberg J., Nathanson L.A., et al. Anion gap as a screening tool for elevated lactate in patients with an increased risk of developing sepsis in the Emergency Department. JEmerg Med 2009, 36:391-394.
49. Wira C.R., Donnino M., Shirazi E., et al. Surrogate markers for lactic acidosis in patients with severe sepsis and septic shock. Crit Care Med 2004, 32:A151.
50. Innocenti F., Bianchi S., Guerrini E., et al. Prognostic scores for early stratification of septic patients admitted to an emergency department-high dependency unit. Eur J Emerg Med 2014, 21(4):254-259.
51. Janssens U., Graf C., Graf J., et al. Evaluation of the SOFA score: a single-center experience of a medical intensive care unit in 303 consecutive patients with predominantly cardiovascular disorders. Sequential Organ Failure Assessment. Intensive Care Med 2000, 26:1037-1045.
52. Gando S., Saitoh D., Ogura H., et al. Amulticenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care 2013, 17:R111.
53. Shapiro N.I., Howell M.D., Talmor D., et al. Mortality in Emergency Department Sepsis (MEDS) score predicts 1-year mortality. Crit Care Med 2007, 35:192-198.
54. Trzeciak S., Dellinger R.P., Parrillo J.E., et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007, 49:88-98. 98.e1-2.
55. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
56. Spies C., Haude V., Fitzner R., et al. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 1998, 113:1055-1063.
57. Mehta N.J., Khan I.A., Gupta V., et al. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004, 95:13-17.
58. Turner A., Tsamitros M., Bellomo R. Myocardial cell injury in septic shock. Crit Care Med 1999, 27:1775-1780.
59. ver Elst K.M., Spapen H.D., Nguyen D.N., et al. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000, 46:650-657.
60. Pope J.V., Jones A.E., Gaieski D.F., et al. Multicenter study of central venous oxygen saturation (ScvO(2)) as a predictor of mortality in patients with sepsis. Ann Emerg Med 2010, 55:40-46.e1.
61. Varpula M., Tallgren M., Saukkonen K., et al. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005, 31:1066-1071.
62. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. NEngl J Med 2001, 345:1368-1377.
63. Friedman G., Silva E., Vincent J.L. Has the mortality of septic shock changed with time. Crit Care Med 1998, 26:2078-2086.
64. Guidet B., Martinet O., Boulain T., et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012, 16:R94.
65. Bayer O., Reinhart K., Kohl M., et al. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med 2012, 40:2543-2551.
66. Myburgh J.A., Finfer S., Bellomo R., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. NEngl J Med 2012, 367:1901-1911.
67. Schortgen F., Lacherade J.C., Bruneel F., et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357:911-916.
68. McIntyre L.A., Fergusson D., Cook D.J., et al. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial. Can J Anaesth 2008, 55:819-826.
69. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. NEngl J Med 2008, 358:125-139.
70. Perner A., Haase N., Guttormsen A.B., et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. NEngl J Med 2012, 367:124-134.
71. Packman M.I., Rackow E.C. Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 1983, 11:165-169.
72. Diebel L.N., Wilson R.F., Tagett M.G., et al. End-diastolic volume. A better indicator of preload in the critically ill. Arch Surg 1992, 127:817-821. [discussion: 821-2].
73. Osman D., Ridel C., Ray P., et al. Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med 2007, 35:64-68.
74. Bindels A.J., van der Hoeven J.G., Graafland A.D., et al. Relationships between volume and pressure measurements and stroke volume in critically ill patients. Crit Care 2000, 4:193-199.
75. Sakka S.G., Bredle D.L., Reinhart K., et al. Comparison between intrathoracic blood volume and cardiac filling pressures in the early phase of hemodynamic instability of patients with sepsis or septic shock. JCrit Care 1999, 14:78-83.
76. Calvin J.E., Driedger A.A., Sibbald W.J. Does the pulmonary capillary wedge pressure predict left ventricular preload in critically ill patients?. Crit Care Med 1981, 9:437-443.
77. Boulain T., Achard J.M., Teboul J.L., et al. Changes in BP induced by passive leg raising predict response to fluid loading in critically ill patients. Chest 2002, 121:1245-1252.
78. Lafanechere A., Pene F., Goulenok C., et al. Changes in aortic blood flow induced by passive leg raising predict fluid responsiveness in critically ill patients. Crit Care 2006, 10:R132.
79. Monnet X., Rienzo M., Osman D., et al. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med 2006, 34:1402-1407.
80. Lamia B., Ochagavia A., Monnet X., et al. Echocardiographic prediction of volume responsiveness in critically ill patients with spontaneously breathing activity. Intensive Care Med 2007, 33:1125-1132.
81. Marik P.E., Cavallazzi R., Vasu T., et al. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med 2009, 37:2642-2647.
82. Michard F., Teboul J.L. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 2002, 121:2000-2008.
83. Feissel M., Michard F., Mangin I., et al. Respiratory changes in aortic blood velocity as an indicator of fluid responsiveness in ventilated patients with septic shock. Chest 2001, 119:867-873.
84. Brennan J.M., Blair J.E., Hampole C., et al. Radial artery pulse pressure variation correlates with brachial artery peak velocity variation in ventilated subjects when measured by internal medicine residents using hand-carried ultrasound devices. Chest 2007, 131:1301-1307.
85. Shapiro N.I., Howell M.D., Talmor D., et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 2006, 34:1025-1032.
86. De Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. NEngl J Med 2010, 362:779-789.
87. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. NEngl J Med 2008, 358:877-887.
88. Morelli A., Ertmer C., Rehberg S., et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care 2008, 12:R143.
89. Hebert P.C., Wells G., Blajchman M.A., et al. Amulticenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. NEngl J Med 1999, 340:409-417.
90. Gao F., Melody T., Daniels D.F., et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 2005, 9:R764-R770.
91. Focht A., Jones A.E., Lowe T.J. Early goal-directed therapy: improving mortality and morbidity of sepsis in the emergency department. Jt Comm J Qual Patient Saf 2009, 35:186-191.
92. Kortgen A., Niederprum P., Bauer M. Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med 2006, 34:943-949.
93. Ferrer R., Artigas A., Levy M.M., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303.
94. Forum NQ. NQF #0500 Severe sepsis and septic shock: management bundle. Last updated date: October 05, 2012. Available at: Accessed January 2, 2014. http://qualityforum.org.
95. Carlbom D.J., Rubenfeld G.D. Barriers to implementing protocol-based sepsis resuscitation in the emergency department-results of a national survey. Crit Care Med 2007, 35:2525-2532.
96. Stoneking L., Denninghoff K., Deluca L., et al. Sepsis bundles and compliance with clinical guidelines. JIntensive Care Med 2011, 26:172-182.
97. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. NEngl J Med 2001, 345:1359-1367.
98. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. NEngl J Med 2006, 354:449-461.
99. Investigators N.S., Finfer S., Chittock D.R., et al. Intensive versus conventional glucose control in critically ill patients. NEngl J Med 2009, 360:1283-1297.
100. Fein A.M., Calalang-Colucci M.G. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin 2000, 16:289-317.
101. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
102. Force A.D., Ranieri V.M., Rubenfeld G.D., et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012, 307:2526-2533.
103. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. NEngl J Med 2000, 342:1301-1308.
104. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
105. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. NEngl J Med 2008, 358:111-124.
106. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009, 301:2362-2375.
107. Sligl W.I., Milner D.A., Sundar S., et al. Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis 2009, 49:93-101.
108. Briegel J., Forst H., Haller M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999, 27:723-732.
109. Bollaert P.E., Charpentier C., Levy B., et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998, 26:645-650.
110. Simon L., Gauvin F., Amre D.K., et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217.
111. Uzzan B., Cohen R., Nicolas P., et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003.
112. Faix J.D. Biomarkers of sepsis. Crit Rev Clin Lab Sci 2013, 50:23-36.
113. Brunkhorst F.M., Al-Nawas B., Krummenauer F., et al. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect 2002, 8:93-100.
114. Becker K.L., Snider R., Nylen E.S. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008, 36:941-952.
115. Billeter A., Turina M., Seifert B., et al. Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg 2009, 33:558-566.
116. Clec'h C., Ferriere F., Karoubi P., et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004, 32:1166-1169.
117. Claeys R., Vinken S., Spapen H., et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002, 30:757-762.
118. Karlsson S., Heikkinen M., Pettila V., et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 2010, 14:R205.
119. Lee C.C., Chen S.Y., Tsai C.L., et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 2008, 29:322-327.
120. Charles P.E., Tinel C., Barbar S., et al. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care 2009, 13:R38.
121. Schuetz P., Maurer P., Punjabi V., et al. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care 2013, 17:R115.
122. Magrini L., Travaglino F., Marino R., et al. Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases. Eur Rev Med Pharmacol Sci 2013, 17(Suppl 1):133-142.
123. Koo K.K., Sun J.C., Zhou Q., et al. Pulmonary artery catheters: evolving rates and reasons for use. Crit Care Med 2011, 39:1613-1618.
124. Kircher B.J., Himelman R.B., Schiller N.B. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990, 66:493-496.
125. Moreno F.L., Hagan A.D., Holmen J.R., et al. Evaluation of size and dynamics of the inferior vena cava as an index of right-sided cardiac function. Am J Cardiol 1984, 53:579-585.
126. Jue J., Chung W., Schiller N.B. Does inferior vena cava size predict right atrial pressures in patients receiving mechanical ventilation?. JAm Soc Echocardiogr 1992, 5:613-619.
127. Arbo J.E., Maslove D.M., Beraud A.S. Bedside assessment of right atrial pressure in critically ill septic patients using tissue Doppler ultrasonography. JCrit Care 2013, 28(6):1112.e1-1112.e5.
128. Nagueh S.F., Kopelen H.A., Zoghbi W.A. Relation of mean right atrial pressure to echocardiographic and Doppler parameters of right atrial and right ventricular function. Circulation 1996, 93:1160-1169.
129. Brennan J.M., Blair J.E., Goonewardena S., et al. Reappraisal of the use of inferior vena cava for estimating right atrial pressure. JAm Soc Echocardiogr 2007, 20:857-861.
130. Beigel R., Cercek B., Luo H., et al. Noninvasive evaluation of right atrial pressure. JAm Soc Echocardiogr 2013, 26:1033-1042.
131. Griffee M.J., Merkel M.J., Wei K.S. The role of echocardiography in hemodynamic assessment of septic shock. Crit Care Clin 2010, 26:365-382. table of contents.
132. Macdonald S.P., Brown S.G. Near-infrared spectroscopy in the assessment of suspected sepsis in the emergency department. Emerg Med J 2013, [Epub ahead of print].
133. Creteur J. Muscle StO2 in critically ill patients. Curr Opin Crit Care 2008, 14:361-366.
134. Lipcsey M., Woinarski N.C., Bellomo R. Near infrared spectroscopy (NIRS) of the thenar eminence in anesthesia and intensive care. Ann Intensive Care 2012, 2:11.
135. Skarda D.E., Mulier K.E., Myers D.E., et al. Dynamic near-infrared spectroscopy measurements in patients with severe sepsis. Shock 2007, 27:348-353.
136. Pareznik R., Knezevic R., Voga G., et al. Changes in muscle tissue oxygenation during stagnant ischemia in septic patients. Intensive Care Med 2006, 32:87-92.
137. Nardi O., Gonzalez H., Fayssoil A., et al. Masseter muscle oxygen saturation is associated with central venous oxygen saturation in patients with severe sepsis. JClin Monit Comput 2010, 24:289-293.
138. Mulier K.E., Skarda D.E., Taylor J.H., et al. Near-infrared spectroscopy in patients with severe sepsis: correlation with invasive hemodynamic measurements. Surg Infect (Larchmt) 2008, 9:515-519.
139. Napoli A.M., Machan J.T., Forcada A., et al. Tissue oxygenation does not predict central venous oxygenation in emergency department patients with severe sepsis and septic shock. Acad Emerg Med 2010, 17:349-352.
140. Shapiro N.I., Arnold R., Sherwin R., et al. The association of near-infrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit Care 2011, 15:R223.
141. Vorwerk C., Coats T.J. The prognostic value of tissue oxygen saturation in emergency department patients with severe sepsis or septic shock. Emerg Med J 2012, 29:699-703.
142. Zhou F., Peng Z., Murugan R., et al. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med 2013, 41:2209-2220.
143. Qiu P., Cui X., Sun J., et al. Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysis. Crit Care Med 2013, 41:2419-2429.
144. Harjai M., Bogra J., Kohli M., et al. Is suppression of apoptosis a new therapeutic target in sepsis?. Anaesth Intensive Care 2013, 41:175-183.
145. Zapelini P.H., Rezin G.T., Cardoso M.R., et al. Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. Mitochondrion 2008, 8:211-218.
146. Piel D.A., Deutschman C.S., Levy R.J. Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis. Shock 2008, 29:612-616.